Difference between revisions of "PE000046"
Jump to navigation
Jump to search
(Created page with "{{Peptide |glycan=G00912UN;N11 |mw=4586.929 |name=K.AALAAFNAQNN{{!(}}H5N4S2{{!)}}GSNFQLEEISR.A |nox=0 |nrt=90.596 |nrtobs=13 |sequence=AALAAFNAQNNGSNFQLEEISR }}{{Alignment |en...") |
|||
| Line 13: | Line 13: | ||
|prsites=N176 | |prsites=N176 | ||
|raa=A | |raa=A | ||
| + | |site=P02765@N176 | ||
|start=166 | |start=166 | ||
}} | }} | ||
Latest revision as of 20:18, 26 May 2021
| Name | K.AALAAFNAQNN[H5N4S2]GSNFQLEEISR.A |
|---|---|
| Sequence | AALAAFNAQNNGSNFQLEEISR |
| Glycans(s) | H5N4S2 (N11) |
| Mod(s) | |
| Molecular Weight | 4586.929 |
| Norm. RT | 90.596 |
| Protein | AHSG (P02765) |
Samples
DDA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Transitions | |
|---|---|---|---|---|---|---|---|---|
| TG003867 | 50.030 | 48.922 | 87.363 | 1,523.981 | 3 | Orbitrap | Human Serum | 6 |
| TG001463 | 49.184 | 48.178 | 90.867 | 1,143.237 | 4 | Orbitrap | Human Serum | 8 |
| TG002363 | 49.081 | 48.715 | 90.140 | 1,143.237 | 4 | Orbitrap | Human Serum | 8 |
| TG003828 | 50.030 | 48.997 | 87.575 | 1,143.237 | 4 | Orbitrap | Human Serum | 6 |
| TG005096 | 50.378 | 50.404 | 92.299 | 1,143.237 | 4 | Orbitrap | Human Serum | 4 |
| TG005453 | 68.996 | 68.289 | 94.427 | 1,143.237 | 4 | Orbitrap | Human Serum | 6 |
| TG001066 | 48.888 | 48.147 | 90.966 | 1,143.237 | 4 | Orbitrap | Human Serum | 4 |
| TG004935 | 56.931 | 58.696 | 98.822 | 1,143.237 | 4 | Orbitrap | Human Serum | 5 |
| TG001404 | 49.888 | 48.159 | 90.276 | 1,143.237 | 4 | Orbitrap | Human Serum | 8 |
| TG003646 | 50.621 | 50.840 | 91.690 | 1,143.237 | 4 | Orbitrap | Human Serum | 6 |
| TG000305 | 47.986 | 50.336 | 1,143.237 | 4 | Orbitrap | Human Serum | 5 | |
| TG003097 | 49.928 | 49.384 | 89.827 | 1,143.237 | 4 | Orbitrap | Human Serum | 5 |
| TG005347 | 73.511 | 73.640 | 107.136 | 1,143.237 | 4 | Orbitrap | Human Serum | 6 |
| TG001733 | 48.406 | 48.221 | 90.596 | 1,143.237 | 4 | Orbitrap | Human Serum | 8 |
| TG004982 | 54.951 | 54.435 | 89.805 | 1,143.237 | 4 | Orbitrap | Human Serum | 4 |
| TG001195 | 48.351 | 48.199 | 92.098 | 1,523.981 | 3 | Orbitrap | Human Serum | 10 |
DIA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Intensity | |
|---|---|---|---|---|---|---|---|---|
| TG003948 | 49.085 | 49.085 | 91.358 | 1,523.981 | 3 | Orbitrap | Human Serum | 6,935,090 |
| TG003949 | 49.067 | 49.067 | 91.313 | 1,143.237 | 4 | Orbitrap | Human Serum | 2,014,530 |
| TG008509 | 36.612 | 36.612 | 83.878 | 1,143.237 | 4 | TripleTOF | Human Serum | 1,694,580 |
| TG008202 | 36.550 | 36.550 | 82.892 | 1,143.237 | 4 | TripleTOF | Human Serum | 1,557,790 |
| TG008804 | 36.672 | 36.672 | 82.189 | 1,143.237 | 4 | TripleTOF | Human Serum | 1,551,820 |
| TG009118 | 36.037 | 36.037 | 83.657 | 1,143.237 | 4 | TripleTOF | Human Serum | 1,476,150 |
| TG009421 | 36.586 | 36.586 | 83.423 | 1,143.237 | 4 | TripleTOF | Human Serum | 1,379,340 |
| TG009795 | 36.636 | 36.636 | 84.472 | 1,143.237 | 4 | TripleTOF | Human Serum | 498,139 |
| TG010643 | 36.390 | 36.390 | 82.641 | 1,143.237 | 4 | TripleTOF | Human Serum | 435,973 |
| TG010240 | 36.601 | 36.601 | 84.201 | 1,143.237 | 4 | TripleTOF | Human Serum | 416,392 |
| TG006875 | 36.658 | 36.658 | 84.467 | 1,143.237 | 4 | TripleTOF | Human Serum | 59,298 |
| TG007355 | 36.600 | 36.600 | 84.098 | 1,143.237 | 4 | TripleTOF | Human Serum | 58,992.9 |
| TG007910 | 36.516 | 36.516 | 83.979 | 1,143.237 | 4 | TripleTOF | Human Serum | 57,890.4 |
| TG007627 | 36.732 | 36.732 | 88.089 | 1,143.237 | 4 | TripleTOF | Human Serum | 53,937.7 |
| TG004599 | 34.821 | 34.821 | 86.310 | 1,523.981 | 3 | TripleTOF | Human Serum | 597.934 |
| TG004482 | 35.206 | 35.206 | 89.927 | 1,143.237 | 4 | TripleTOF | Human Serum | 268.878 |